Viking Therapeutics Statistics
Total Valuation
VKTX has a market cap or net worth of $3.31 billion. The enterprise value is $2.81 billion.
| Market Cap | 3.31B |
| Enterprise Value | 2.81B |
Important Dates
The next estimated earnings date is Wednesday, October 21, 2026, after market close.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VKTX has 116.65 million shares outstanding. The number of shares has increased by 2.64% in one year.
| Current Share Class | 116.65M |
| Shares Outstanding | 116.65M |
| Shares Change (YoY) | +2.64% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 2.46% |
| Owned by Institutions (%) | 65.68% |
| Float | 113.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.11 |
| P/TBV Ratio | 8.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.72 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -70,002.63 |
Financial Efficiency
Return on equity (ROE) is -88.85% and return on invested capital (ROIC) is -57.91%.
| Return on Equity (ROE) | -88.85% |
| Return on Assets (ROA) | -51.86% |
| Return on Invested Capital (ROIC) | -57.91% |
| Return on Capital Employed (ROCE) | -135.85% |
| Weighted Average Cost of Capital (WACC) | 7.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$8.23M |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.51% in the last 52 weeks. The beta is 0.65, so VKTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -4.51% |
| 50-Day Moving Average | 33.11 |
| 200-Day Moving Average | 33.10 |
| Relative Strength Index (RSI) | 38.91 |
| Average Volume (20 Days) | 8,631,441 |
Short Selling Information
The latest short interest is 22.58 million, so 19.36% of the outstanding shares have been sold short.
| Short Interest | 22.58M |
| Short Previous Month | 22.19M |
| Short % of Shares Out | 19.36% |
| Short % of Float | 19.86% |
| Short Ratio (days to cover) | 12.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -560.02M |
| Pretax Income | -534.80M |
| Net Income | -534.80M |
| EBITDA | n/a |
| EBIT | -560.02M |
| Earnings Per Share (EPS) | -$4.67 |
Balance Sheet
The company has $501.66 million in cash and $4.09 million in debt, with a net cash position of $497.58 million or $4.27 per share.
| Cash & Cash Equivalents | 501.66M |
| Total Debt | 4.09M |
| Net Cash | 497.58M |
| Net Cash Per Share | $4.27 |
| Equity (Book Value) | 408.32M |
| Book Value Per Share | 3.50 |
| Working Capital | 407.91M |
Cash Flow
| Operating Cash Flow | -418.44M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 450,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -418.44M |
| FCF Per Share | -$3.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.64% |
| Shareholder Yield | -2.64% |
| Earnings Yield | -16.15% |
| FCF Yield | -12.64% |
Analyst Forecast
The average price target for VKTX is $94.82, which is 234.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $94.82 |
| Price Target Difference | 234.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |